PRMT1 and hepatocellular carcinoma: Interestingly, inhibition of STAT3 phosphorylation using crypto tanshinone, a STAT3 inhibitor, reversed this process, highlighting PRMT1’s involvement in multiple regulatory mechanisms of the STAT3 pathway and suggesting its potential as a therapeutic target in HCC [70].